Introduction {#Sec1}
============

Even after successful resuscitation and return of spontaneous circulation (ROSC), cardiac arrest carries a poor prognosis with limited options for treatment \[[@CR1], [@CR2]\]. In addition to controlling temperature after cardiac arrest, optimizing ventilation and oxygenation may improve outcome \[[@CR3]\]. International consensus currently recommends careful monitoring of post-resuscitation ventilation for neurological and cardiovascular outcome \[[@CR4]\]. Indeed, targeting safe levels of carbon dioxide and oxygen in arterial blood may limit global ischemic damage and enhance oxygenation and blood flow. Aberrant arterial levels have repeatedly been shown to be associated with worse outcome after cardiac arrest, but the effects may depend on degree and duration of the (concurrent) exposure \[[@CR5]--[@CR14]\]. Recently, a large cohort study was performed in 125 intensive care units (ICUs) in Australia and New Zealand, which showed that abnormal concentrations of arterial carbon dioxide (PaCO~2~) were common after cardiac arrest \[[@CR15]\]. Compared with normocapnia, hypocapnia was independently associated with worse clinical outcomes, whereas hypercapnia was associated with a greater likelihood of good outcome. The results were reproduced in a smaller cohort \[[@CR16]\] and are supported by pediatric \[[@CR17]\] and experimental research \[[@CR18]--[@CR20]\]. However, ventilation and oxygenation are closely related and effects of PaCO~2~ may not be independent from arterial oxygen levels (PaO~2~). In this study, we aimed to investigate the separate and combined effects of both parameters in a multicenter cohort of patients admitted to Dutch ICUs after cardiac arrest.

Methods {#Sec2}
=======

Data collection {#Sec3}
---------------

Analyses were performed on patient data retrieved from 82 ICUs of teaching and non-teaching hospitals participating in the Dutch National Intensive Care Evaluation (NICE) registry between 2007 and 2012. The NICE registry is a high quality ICU database, which is subject to multiple quality checks and local audits in accordance with applicable research and ethical protocols \[[@CR21]\]. In brief, the registry contains all clinical data required to calculate mortality risk predictions according to, among others, the Acute Physiology and Chronic Health Evaluation (APACHE) IV for all consecutive ICU patients. The registry does not contain variables determining the cause and circumstances of the cardiac arrest and resuscitation. For the analyses, data obtained from routine care and without patient identifying information were used and consent was therefore not needed according to the Dutch Personal Data Protection Act.

In 2012, approximately 90 % of all Dutch ICUs recorded the data for their patients in the registry. In accordance with the previously conducted study by Schneider et al. \[[@CR15]\], all adult patients admitted after out-of-hospital cardiac arrest were included. Abstracted data included demographics, comorbidities, arterial blood gas parameters, diagnostic and physiologic information, admission source and illness severity score by means of the APACHE IV.

Data extraction {#Sec4}
---------------

Adult patients admitted to the ICU after out-of-hospital cardiac arrest and cardiopulmonary resuscitation, who were mechanically ventilated at any moment in the first 24 h of admission, were included. We excluded readmissions, trauma patients, nonventilated patients and records not meeting APACHE IV criteria.

As part of the NICE data collection, arterial blood gas (ABG) parameters that were associated with the lowest PaO~2~ to FiO~2~ ratio in the first 24 h after admission were automatically extracted and subsequently used for classification of patients. The APACHE IV score was recalculated (AP4-adj) by standardizing the PaCO~2~ and PaO~2~ to fixed normal values (40 mmHg and 80 mmHg, respectively) in order to prevent overadjustment of these variables in the multivariate models.

Statistical analysis {#Sec5}
--------------------

Univariate and multivariate logistic generalized estimating equation (GEE) regression models, which account for potential correlation of outcome within ICUs, were used to examine the relationship between the primary outcome (hospital mortality) and either PaCO~2~ or PaO~2~. The relationship of PaCO~2~ and PaO~2~ with mortality was plotted in order to inspect the dose--response curve. Considering the nonlinear relationships, the associations were analyzed by modeling each of PaCO~2~ and PaO~2~ as a restricted cubic spline and separately in categorized groups \[[@CR22]\]. PaCO~2~ was categorized in three groups, using conventional thresholds (normocapnia: 35--45 mmHg). PaO~2~ was categorized according to thresholds from previous studies (normoxia: 60--300 mmHg) \[[@CR5], [@CR7]--[@CR9], [@CR23], [@CR24]\]. The individual, joint and interaction effects of two-sided derangements were separately investigated, as suggested for cohort studies \[[@CR25]\]. For a further understanding of the dose--response relationship in multivariate models, PaO~2~ categories were also reanalyzed with alternative thresholds derived from observation percentiles or previously used targets \[[@CR5], [@CR7], [@CR8], [@CR26]\]. Variables extracted from the first 24 h of admission were considered for the multivariate etiological model based on clinical relevance and in accordance with a previously used model \[[@CR15]\]. Considered covariates were introduced separately to the univariate models in order to estimate the unadjusted effect and included age, gender, AP4-adj, year of admission, admission source, therapeutic hypothermia and lowest glucose as a possible proxy-marker of less attentive care \[[@CR24]\]. Covariates were subsequently identified as confounders for the outcome using the 10 % change-in-estimate method \[[@CR27]\]. Hence, the final multivariate GEE models consisted of age, lowest glucose, AP4-adj and either PaCO~2~ or PaO~2~. Collinearity among the covariates was inspected by estimating Pearson or Spearman correlation coefficients as appropriate. Routine temperature correction of arterial blood gas results is uncommon in Dutch ICUs and was performed according to the participating site's practice. To account for multiple testing, the statistical significance level for the P-value was set at 0.01.

All analyses were conducted using SPSS version 21 (IBM Corp, Armonk, NY, USA) and R version 3.0.1 (R Foundation for Statistical Computing, Vienna, Austria).

Results {#Sec6}
=======

Data from 6,496 out-of-hospital cardiac arrest patients and 82 hospitals were extracted from the NICE registry and screened for enrollment (Additional file [1](#MOESM1){ref-type="media"}: Figure S1). The main reasons for exclusion were no mechanical ventilation (n = 196), missing valid ABG data (n = 379) and not fulfilling APACHE IV criteria (n = 314).

Descriptive characteristics of the 5,258 included patients are summarized in Table [1](#Tab1){ref-type="table"}. The median age was 66 (interquartile range \[IQR\] 56--76) and patients were predominantly male (69.6 %). Median PaCO~2~ was 42 mmHg (IQR 36--49) and median PaO~2~ was 92 mmHg (IQR 75--124). Of all patients, 21.6 % were classified as hypocapnic, 43.5 % as normocapnic and 34.9 % as hypercapnic. Patients were further classified as hypoxic (8 %), normoxic (89.3 %) or hyperoxic (2.7 %). The majority of patients (87.4 %) were admitted to the ICU from the emergency room of the same hospital. The unadjusted mean APACHE IV score was 117.3, with the normocapnia and the normoxia groups showing the lowest mean (P \< 0.001). Groups were relatively balanced in terms of admission source, comorbidities, temperature, glucose and non-respiratory markers.Table 1Descriptive characteristics**Characteristic**  All patientsPaCO~2~ groupPaO~2~ groupHypocapniaNormocapniaHypercapnia*P* valueHypoxiaNormoxiaHyperoxia*P* valueNo. (%) of patients52581136 (21.6)2288 (43.5)1834 (34.9)418 (8.0)4696 (89.3)144 (2.7)**Baseline characteristics**Age (years)66 (56--76)68 (56--77)66 (56--76)65 (55--74)\<0.00169 (57--78)66 (56--75)67 (56--77)0.02Male gender, n (%)3661 (69.6)737 (64.9)1601 (70.0)1323 (72.1)\<0.001294 (70.3)3269 (69.6)98 (68.1)0.87Admission source, n (%) Operating room from emergency room same hospital182 (3.5)32 (2.8)95 (4.2)55 (3.0)0.0514 (3.3)166 (3.5)2 (1.4)0.38 Emergency room same hospital4578 (87.1)981 (86.4)1972 (86.2)1625 (88.6)0.05367 (87.8)4077 (86.8)134 (93.1)0.08 Operating room from emergency room other hospital4 (0.1)1 (0.1)1 (\<0.1)2 (0.1)0.7404 (0.1)00.79 Emergency room other hospital183 (3.5)41 (3.6)81 (3.5)61 (3.3)0.9016 (3.8)166 (3.5)1 (0.7)0.17 Home311 (5.9)81 (7.1)139 (6.1)91 (5.0)0.0521 (5.0)283 (6.0)7 (4.9)0.61Acute renal failure, n (%)660 (12.6)154 (13.6)242 (10.6)264 (14.4)\<0.00179 (18.9)565 (12.0)16 (11.1)\<0.001Chronic co-morbidities, n (%) Cardiovascular disease380 (7.2)94 (8.3)158 (6.9)128 (7.0)0.3030 (7.2)340 (7.2)10 (6.9)0.99 Renal disease319 (6.1)87 (7.7)137 (6.0)95 (5.2)0.0424 (5.7)287 (6.1)8 (5.6)0.91 Respiratory disease225 (4.3)33 (2.9)72 (3.1)120 (6.5)\<0.00126 (6.2)191 (4.1)8 (5.6)0.08 Cirrhosis44 (0.8)16 (1.4)14 (0.6)14 (0.8)0.059 (2.2)35 (0.7)0\<0.01 Cancer106 (2.0)25 (2.2)48 (2.1)33 (1.8)0.626 (1.4)96 (2.0)4 (2.8)0.57Markers of severity, APACHE IV score117.3 (29.69)117.5 (29.10)114.6 (30.52)120.4 (28.68)\<0.001132.2 (29.22)115.9 (29.47)119.5 (26.21)\<0.001 APACHE IV risk of death80.7 (65.3-90.0)81.2 (66.2-90.2)79.2 (63.0-89.2)82.5 (68.2-91.1)\<0.00188.8 (78.1-94.0)79.8 (64.3-89.4)81.9 (64.9-89.4)\<0.001Physiological parameters obtained within the first 24 h in the intensive care unitTemperature Highest temperature (°C)35.7 (34.8-36.9)35.8 (34.7-37.0)35.7 (34.8-36.8)35.8 (34.8-36.9)0.3735.7 (34.6-37.1)35.7 (34.8-36.9)35.9 (34.9-36.8)0.88 Lowest temperature (°C)32.5 (31.8-33.2)32.4 (31.8-33.4)32.5 (31.9-33.2)32.5 (31.9-33.3)0.5532.5 (31.8-33.6)32.5 (31.8-33.2)32.4 (31.7-33.3)0.78Lowest temperature below 34 °C, n (%)4229 (80.4)888 (78.2)1863 (81.4)1478 (80.6)0.08326 (78.0)3788 (80.7)115 (79.9)0.41Heart Rate Highest heart rate, beats/min103 (87--120)102 (85--120)101 (86--119)105 (90--122)\<0.001110 (91--128)102 (87--120)105 (88--125)\<0.001 Lowest heart rate, beats/min55 (45--68)55 (45--69)53 (44--65)55 (45--70)\<0.00155 (45--74)55 (45--67)51 (42--67)0.11Blood pressure (BP) Highest systolic BP (mmHg)150 (134--171)150 (134--170)150 (134--172)150 (133--170)0.61145 (128--165)150 (134--172)156 (139--178)\<0.001 Lowest systolic BP (mmHg)80 (70--90)80 (71--91)81 (70--90)80 (69--89)\<0.00176 (64--86)80 (70--90)82 (70--91)\<0.001Respiratory rate (RR) Highest RR, breaths (min)23 (20--28)23 (19--29)23 (19--28)24 (20--29)\<0.00125 (20--30)23 (20--28)23 (19--28)\<0.01 Lowest RR, breaths (min)14 (12--16)14 (12--16)14 (11--16)14 (12--17)0.0315 (12--18)14 (12--16)14 (12--16)\<0.001Oxygenation PaO~2~ (mmHg)92 (75--124)99 (78--136)94 (76--125)87 (70--116)\<0.00151 (44--56)94 (78--124)359 (320--438)\<0.001 FiO~2~ (%)50 (40--70)45 (40--60)50 (40--62)60 (44--90)\<0.00166 (50--100)50 (40--70)98 (67--100)\<0.001 PaO~2~/FiO~2~ ratio191 (124--272)227 (157--316)203 (134--283)158 (100--228)\<0.00171 (55--100)198 (136--272)440 (361--550)\<0.001Carbon dioxide PaCO~2~ (mmHg)42 (36--49)31 (28--33)40 (38--43)52 (48--59)\<0.00145 (38--54)41 (35--48)40 (34--48)\<0.001Metabolic Lowest glucose (mmol l^−1^)6.0 (4.8-7.4)5.9 (4.8-7.3)6.0 (4.8-7.3)6.1 (4.8-7.5)0.656.2 (4.8-7.9)6.0 (4.8-7.3)6.1 (5.0-7.8)0.13Acid--base balance Lowest pH7.28 (0.12)7.37 (0.11)7.30 (0.10)7.20 (0.12)\<0.0017.24 (0.14)7.29 (0.12)7.26 (0.14)\<0.001 Highest HCO~3~ - (mmol l^−1^)22.3 (3.92)20.8 (3.67)22.1 (3.54)23.5 (4.16)\<0.00122.8 (4.70)22.3 (3.85)22.0 (3.89)0.43 Lowest HCO~3~ - (mmol l^−1^)17.4 (4.33)16.0 (4.17)17.4 (4.03)18.3 (4.54)\<0.00116.6 (4.96)17.5 (4.27)17.2 (4.10)\<0.01Data presented as total number (percentage), mean (standard deviation) or median (interquartile range) depending on underlying data distributionP-values for group comparisons using ANOVA or Kruskal-Wallis according to data distribution*APACHE* Acute Physiology and Chronic Health Evaluation, *ANOVA* Analysis of variance

Unadjusted outcome {#Sec7}
------------------

Table [2](#Tab2){ref-type="table"} shows the unadjusted mortality rates. Overall, 2,491 (47.4 %) patients died in the ICU and 2,833 (53.9 %) died in the hospital. Hospital mortality was highest in the hypocapnia group (58.4 %), compared with the hypercapnia (56.8 %) and normocapnia (49.3 %) group (P \< 0.001). Compared with the hyperoxia (57.6 %) and normoxia (52.9 %) groups, hospital mortality was higher (P \< 0.001) in the hypoxia group (63.6 %).Table 2Unadjusted mortality rates**Outcome**  All patientsPaCO~2~ groupPaO~2~ groupHypocapniaNormocapniaHypercapnia*P* valueHypoxiaNormoxiaHyperoxia*P* valueIntensive care unit mortality2491 (47.4)576 (50.7)976 (42.7)939 (51.2)\<0.001244 (58.4)2171 (46.2)76 (52.8)\<0.001In-hospital mortality2833 (53.9)663 (58.4)1129 (49.3)1041 (56.8)\<0.001266 (63.6)2484 (52.9)83 (57.6)\<0.001Data presented as total number (percentage) per group. P-values for group comparisons using Chi-squared test

In the univariate logistic regression model, PaCO~2~ was significantly associated with mortality (P \< 0.001). This model was improved when PaO~2~ was added (P \< 0.001). No interaction effect (arterial oxygen by arterial carbon dioxide concentration) on mortality was found (P = 0.25). PaO~2~ was also univariately associated with hospital mortality (P \< 0.001).

Adjusted outcomes {#Sec8}
-----------------

Both PaCO~2~ and PaO~2~ showed a curvilinear U-shaped relationship with mortality in adjusted analyses (Figs. [1](#Fig1){ref-type="fig"} and [2](#Fig2){ref-type="fig"}). Odds ratios from multivariate analyses are listed in Table [3](#Tab3){ref-type="table"}. After adjustment for age, lowest glucose, AP4-adj and PaO~2~ (splines), hypocapnia showed a significant association with hospital mortality (P \< 0.001), whereas hypercapnia did not. When this model was reanalyzed without adjustment for PaO~2~, the results were virtually unchanged (data not shown).Fig. 1Adjusted probability of in-hospital death by arterial carbon dioxide levels. Loess smoothing curve predicted from logistic regression model adjusted for spline functions of age, lowest glucose, AP4-adj and PaO~2~. Grey zones represent 95 % confidence intervalsFig. 2Adjusted probability of in-hospital death by arterial oxygen levels. Loess smoothing curve predicted from logistic regression model adjusted for spline functions of age, lowest glucose, AP4-adj and PaCO~2~. Grey zones represent 95 % confidence intervalsTable 3Adjusted associations between subgroups and hospital mortality**Group comparison**  Odds ratio (95 % CI)*P* valuePaCO~2~ groups Hypocapnia vs. normocapnia1.39 (1.18--1.63)^a^\<0.001 Hypercapnia vs. normocapnia1.10 (0.95--1.27)^a^0.20 Hypercapnia vs. hypocapnia0.79 (0.67--0.94)^a^\<0.01PaO~2~ groups Hypoxia vs. normoxia1.34 (1.08--1.66)^b^\<0.01 Hyperoxia vs. normoxia1.13 (0.81--1.57)^b^0.46 Hyperoxia vs. hypoxia0.85 (0.58--1.24)^b^0.39Alternative PaO~2~ categories^c^ 55-80 vs. \>300 mmHg1.06 (0.76--1.50)^b^0.72 80-102 vs. \>300 mmHg0.90 (0.64--1.27)^b^0.55 102-300 vs. \>300 mmHg0.79 (0.56--1.11)^b^0.17Hypocapnia = PaCO~2~ \< 35 mmHg; normocapnia = PaCO~2~ 35--45 mmHg; hypercapnia = PaCO~2~ \> 45 mmHgHypoxia = PaO~2~ \< 60 mmHg; normoxia = PaO~2~ 60--300 mmHg; hyperoxia = PaO~2~ \> 300 mmHg^a^Multivariable analysis adjusted for age, lowest glucose, AP4-adj and PaO~2~ (splines)^b^Multivariable analysis adjusted for age, lowest glucose, AP4-adj and PaCO~2~ (splines)^c^Stratification based on thresholds from ARDSnet oxygenation target (55--80 mmHg), upper threshold of median cohort quintile (102 mmHg), and threshold from previous studies (300 mmHg)

Adjusted for age, lowest glucose, AP4-adj and PaCO~2~(splines), hypoxia but not hyperoxia was found to be associated with hospital mortality in comparison to normoxia (P \< 0.01). When this model was reanalyzed without adjustment for PaCO~2~ the results were not materially different (data not shown). When the model was reanalyzed with hyperoxia (\>300 mmHg) as reference category, no effects on mortality were observed for various oxygenation ranges.

The individual and joint effect estimates for derangements (normal range vs. outside normal range) of both parameters are listed in Table [4](#Tab4){ref-type="table"}. Aberrant levels of both PaCO~2~ and PaO~2~ were independently associated with hospital mortality (P \< 0.01). The estimate for the interaction term (presence of PaCO~2~ derangement by presence of PaO~2~ derangement) was not significant on a multiplicative scale (P = 0.75).Table 4Associations between derangements and hospital mortalityVariableUnadjusted odds ratio (95 % CI)Adjusted odds ratio (95 % CI)*P* valuePaCO~2~ derangement vs. normocapnia1.38 (1.24--1.54)1.21 (1.07--1.36)^a^0.003PaO~2~ derangement vs. normoxia1.45 (1.21--1.74)1.27 (1.05--1.54)^b^0.01Interaction term-1.07 (0.71--1.62)0.75PaCO~2~ derangement = PaCO~2~ \< 35 or PaCO~2~ \> 45 mmHg; normocapnia = PaCO~2~ 35--45 mmHgPaO~2~ derangement = PaO~2~ \< 60 or PaO~2~ \> 300 mmHg; normoxia = PaO~2~ 60--300 mmHg^a^Multivariable analysis adjusted for age, lowest glucose, AP4-adj and PaO~2~ (splines)^b^Multivariable analysis adjusted for age, lowest glucose, AP4-adj and PaCO~2~ (splines)*CI* confidence interval

Discussion {#Sec9}
==========

In accordance with previous studies, we found that early exposure to both hypo- and hypercapnia is common in ICU patients resuscitated from cardiac arrest \[[@CR15], [@CR16]\]. In contrast, hypoxia and severe hyperoxia are uncommon findings early in the ICU stay of Dutch hospitals. Both PaCO~2~ and PaO~2~ had a U-shaped relationship with outcome and after adjustment for known confounders, hypocapnia and hypoxia were significantly associated with hospital mortality. Hyperoxia was not independently associated with higher mortality in comparison with various ranges for normoxia. However, this study may lack power to detect significant associations for severe arterial oxygen derangements considering the low prevalence in the present cohort.

Our adjusted mortality plots and the categorized results stress the importance of aberrant arterial levels after cardiac arrest, but rigid cut-offs for optimal ranges remain to be determined and validated. Increasing mortality rates may be skewed towards extreme PaO~2~ levels in the early phase after cardiac arrest. In line, PaCO~2~ levels between 40 and 45 mmHg appear to be favorable shortly after ICU admission. The complex U-shape of the survival curves for both parameters may explain the heterogeneity in previously observed associations \[[@CR14]\]. It shows that unfavorable effects cannot be consistently captured when the results are stratified by groups based on arbitrary thresholds. Indeed, studies assessing arterial hyperoxia with lower thresholds usually failed to show significant effects on outcome, whereas higher risks were observed with substantially higher upper limits \[[@CR5]--[@CR9]\]. The current findings validate the recent calls for caution with hyperoxia in cardiac arrest patients only to a limited extent. The prevalence in this cohort shows that hypoxia and hyperoxia are not a common concern shortly after cardiac arrest patients are admitted to Dutch ICUs. In the analyses of those conditions, the relatively small number of exposed patients increases the probability of type 2 errors. Associations are, therefore, more likely to be consistent with increasing statistical power in the studied subgroups. Moreover, reanalyzing the adjusted effects of oxygenation based on quintiles did not detect a significant association with mortality (data not shown). Hypothesizing that physicians would avoid hypoxia most attentively in the most critically ill patients, hyperoxia could be an indirect marker of illness severity or responsive care, and could thereby reflect a worse outcome. Accordingly, hypoxia and hypocapnia may also be markers of less attentive care or prehospital injury.

The absence of a significant interaction effect between PaCO~2~ and PaO~2~ suggests that it is mainly the effect of the individual variables that influences mortality in our model rather than the absolute effect caused by the interaction between the two variables. The effect of PaO~2~ on hospital mortality is therefore not likely to differ significantly across strata of PaCO~2~, or vice versa. Further, the effect size did not significantly depend on the concurrent presence of aberrant arterial carbon dioxide and arterial oxygen levels. Conditions in which both parameters are concurrently and strongly modified may, therefore, not synergistically increase the risk. However, the univariate associations of PaCO~2~ and PaO~2~ were subtly altered when adjusted for each other and both parameters should, therefore, judiciously be considered as possible confounders.

For our analyses, we were restricted to the variables that were collected as part of the NICE registry. Our database does not contain prehospital variables, nor does it include all ABG samples per admission, but only a single measurement associated with the worst oxygenation in the first 24 h. Although this method has not previously been shown to be inferior, the selected data may not be the most representative data over the total ICU stay and may, therefore, misclassify patients. In addition, selecting either the first, worst or highest value from arterial blood gas sampling emerges as an essential methodological issue for the intended analyses \[[@CR28]\]. The first measured sample may reflect pre-ICU treatment, including oxygen administration in the ambulance and emergency department. Early oxygen administration can influence oxidative metabolism, respiratory markers, vasoconstrictive status and blood flow \[[@CR29]--[@CR31]\], and may thus be an important predictor of outcome. In fact, both highest and lowest systolic blood pressures were significantly higher in the hyperoxia groups. Further, hyperoxia frequently coincides with hyperventilation and concurrent hypocapnia \[[@CR32]\]. Interestingly, systemic blood pressures were very similar across the PaCO~2~ subgroups in this cohort. PaCO~2~ could yet be an important mediator in vascular effects, cardiopulmonary resuscitation and cerebral perfusion \[[@CR13], [@CR33]\]. In view of that, the association between hypocapnia and mortality may be explained by cerebral vasoconstriction, whereas hypercapnia may be less harmful due to increased peripheral tissue oxygenation \[[@CR34]--[@CR38]\].

Although our findings are observational and do not necessarily imply causality, the present results are supported by previous results \[[@CR5], [@CR15]\]. Our findings regarding hyperoxia are in line with several recent studies \[[@CR8], [@CR23], [@CR39]\], even though conflicting results have been documented \[[@CR6], [@CR7], [@CR24], [@CR40]\]. Parts of the heterogeneity in previous findings may be attributed to the adjustment for PaCO~2~. Pure oxygen therapy after cardiac arrest has previously been shown to worsen neurological outcome in animal models \[[@CR41]\] and exposure to hypocapnia and hypercapnia after ROSC has been associated with poor neurological function at hospital discharge \[[@CR16]\]. However, the effects of PaO~2~ targets on neurological recovery of critically ill patients are still uncertain.

In contrast to the previous study by Schneider et al. \[[@CR15]\], both the unadjusted and adjusted association between mortality and hypocapnia were statistically significant. Specific study differences may be explained by population and methodological differences. Our multivariate model differed slightly and there was less dispersion of the carbon dioxide concentrations in our data. Other notable differences between both studies include the substantially lower median PaO~2~ (92 vs. 106 mmHg), mean FiO~2~ (58 vs. 71 %), and marginally lower mean PaCO~2~ (46 vs. 44 mmHg). Furthermore, the vast majority of patients in our cohort (80 vs. 40 %) reached a temperature lower than 34 °C during the first 24 h of ICU admission. Under these conditions, PaCO~2~ and PaO~2~ progressively decrease with decreasing body temperature and the occurrence of hypocapnia and hypoxia may be underestimated with uncorrected ABG levels. However, temperature correction of ABG measurements is ambiguous and was not routinely performed in our study or in the study by Schneider et al.

In order to consistently assess the relationship between risk factors and outcome, it is important to re-evaluate previously established associations in different populations using robust methodology. The modified methodology of the present study provides further insights into the independent and combined effects of PaCO~2~ and PaO~2~ and accounts for clustering by hospital, interaction effects and model variances. Still, residual confounding by prehospital and Utstein variables cannot be ruled out, and derangements may not be isolated risk factors for mortality.

Conclusions {#Sec10}
===========

In this multicenter cohort study, we have studied the survival probability inferred from different levels of PaCO~2~ and PaO~2~ in post cardiac arrest patients. Most effects were attenuated after adjustment for identified confounders, but hypocapnia and hypoxia were independently associated with hospital mortality. The close relationship between both parameters argues for a concurrent assessment of the effects and further evaluation of target ranges is warranted.

Key messages {#Sec11}
============

After resuscitation from cardiac arrest, exposure of patients to both hypo- and hypercapnia is common within 24 h of ICU admissionHypoxia and severe hyperoxia are uncommon findings early in the ICU stayBoth PaCO~2~ and PaO~2~ had an independent U-shaped relationship with hospital mortalityAfter adjustment for relevant confounders, hypocapnia and hypoxia were significant predictors of hospital mortalityA synergistic effect of concurrent derangements of PaCO~2~ and PaO~2~ was not observed
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